Your browser doesn't support javascript.
loading
Tumor eradicated by combination of imiquimod and OX40 agonist for in situ vaccination.
Chu, Yanhong; Li, Rutian; Qian, Lingyu; Liu, Fangcen; Xu, Ruihan; Meng, Fanyan; Ke, Yaohua; Shao, Jie; Yu, Lixia; Liu, Qin; Liu, Baorui.
Afiliação
  • Chu Y; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • Li R; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • Qian L; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • Liu F; Department of Oncology, Rudong Peoples' Hospital of Jiangsu Province, Nantong, China.
  • Xu R; Department of Pathology, Affiliated Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
  • Meng F; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • Ke Y; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • Shao J; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • Yu L; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • Liu Q; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • Liu B; The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Cancer Sci ; 112(11): 4490-4500, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34537997
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Vacinas Anticâncer / Receptores OX40 / Imiquimode / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Vacinas Anticâncer / Receptores OX40 / Imiquimode / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido